Observational studyBMC pediatrics2026
Pediatric tuina combined with glycerin enema in the management of pediatric intussusception: an observational study.
Observational study in BMC pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
objectiveTo investigate the clinical efficacy and safety of pediatric tuina combined with glycerin enema for pediatric intussusception, in order to reduce unnecessary invasive procedures, enhance the safety of intussusception reduction, and conserve medical resources.
methodsThis was an observational study of routine clinical practice with a non-randomized, single-arm design. A total of 128 children diagnosed with intussusception in Zigong Maternal and Child Health Care Hospital from September 2024 to November 2025 were enrolled as the research subjects, including 58 males and 70 females. All children had an onset time of less than 48 h, and color Doppler ultrasound indicated intussusception accompanied by at least one related clinical symptom (abdominal pain, vomiting, paroxysmal crying, etc.). All children received pediatric tuina combined with glycerin enema via anal administration as the first-line treatment in accordance with the standardized diagnosis and treatment protocol formulated by our hospital. For children with failed reduction after combined treatment, ultrasound-guided hydrostatic enema reduction was further performed; laparoscopic surgery was adopted for those who failed hydrostatic enema reduction. This was a single-arm observational study with no control group.
resultsOf the 128 enrolled children, 1 was excluded due to complicated lymph node invagination. Among 127 children who received the initial combined therapy, successful reduction was achieved in 102 cases, with a success rate of 80.3%. Of the 25 failed cases, 23 achieved successful reduction via ultrasound-guided hydrostatic enema (success rate 88.4%), and the remaining 3 underwent successful laparoscopic reduction. Multivariate analysis identified intussusception type, length ≥ 3 cm, and age as independent risk factors for treatment failure, with the predictive model showing good performance (AUC = 0.797). No severe complications were observed during follow-up.
conclusionPediatric tuina combined with glycerin enema is feasible and safe for selected children with intussusception. This regimen is easy to perform without additional specialized equipment, helps reduce unnecessary primary enema intervention and avoid overtreatment, and may assist in distinguishing transient from fixed intussusception. Even in cases of failed initial reduction, it may provide favorable conditions for subsequent procedures. As a conservative adjuvant therapy in selected patients, this combined modality shows good clinical application potential and deserves further validation in future large-sample, multicenter controlled studies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.